ArticleAnnals of translational medicine2020

Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial.

Zhenyu Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.